8-K//Current report
VYNE Therapeutics Inc. 8-K
Accession 0001628280-25-023478
$VYNECIK 0001566044operating
Filed
May 7, 8:00 PM ET
Accepted
May 8, 8:03 AM ET
Size
274.0 KB
Accession
0001628280-25-023478
Documents
- 8-Kmnlo-20250508.htmPrimary
8-K
- EX-99.1vyne-20250508q12025exx991.htm
EX-99.1
- EX-101.SCHmnlo-20250508.xsd
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
- EX-101.LABmnlo-20250508_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
- EX-101.PREmnlo-20250508_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
- GRAPHICimagea.jpg
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001628280-25-023478-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLmnlo-20250508_htm.xml
IDEA: XBRL DOCUMENT
Issuer
VYNE Therapeutics Inc.
CIK 0001566044
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001566044
Filing Metadata
- Form type
- 8-K
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 8:03 AM ET
- Size
- 274.0 KB